Literature DB >> 22537326

Behavior of repolarization variables during exercise test in the athlete's heart.

Annabella Braschi1, Vincenzo C Francavilla, Maurizio G Abrignani, Lorenzo Todaro, Giuseppe Francavilla.   

Abstract

BACKGROUND: T peak-T end, QT peak/QT ratio and T peak-T end/QT ratio are markers able to test myocardial repolarization homogeneity, their increase has been related to a higher risk of ventricular tachyarrhythmias. These parameters have not yet been studied in left ventricular hypertrophy due to training. Aim of the research was to test the behavior of these variables in the athlete's heart during exercise.
METHODS: We examined 70 athletes, all males, divided into two groups according to the absence or the presence of a left ventricular mass index over 49 g/m(2.7) and a control group composed of 35 healthy, untrained males. All study participants underwent electrocardiogram at rest, transthoracic echocardiogram, and ergometric test. Repolarization markers (QT, corrected QT, QT dispersion, T peak-T end, QT peak/QT, T peak-T end/QT) were calculated at rest, at peak exercise and during recovery.
RESULTS: There was no statistically significant difference among the groups regarding all the parameters studied, except for corrected QT at rest between athletes with left ventricular hypertrophy and control group. The behavior of repolarization markers during exercise was not dissimilar in the three groups.
CONCLUSIONS: Athlete's heart is not associated to any alteration in ventricular repolarization homogeneity, neither at rest nor during physical activity nor during recovery. Training-induced left ventricular hypertrophy does not affect relationship QT parameters/RR interval.
© 2012, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22537326      PMCID: PMC6932093          DOI: 10.1111/j.1542-474X.2012.00495.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  24 in total

1.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

2.  The measurement of the Q-T interval of the electrocardiogram.

Authors:  E LEPESCHKIN; B SURAWICZ
Journal:  Circulation       Date:  1952-09       Impact factor: 29.690

3.  In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans.

Authors:  E Picano; G Pelosi; M Marzilli; F Lattanzi; A Benassi; L Landini; A L'Abbate
Journal:  Circulation       Date:  1990-01       Impact factor: 29.690

4.  Rate-dependence of QT dispersion and the QT interval: comparison of atrial pacing and exercise testing.

Authors:  M Zabel; M R Franz; T Klingenheben; B Mansion; H P Schultheiss; S H Hohnloser
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

5.  Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans.

Authors:  M A Rossi
Journal:  J Hypertens       Date:  1998-07       Impact factor: 4.844

6.  T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion.

Authors:  Masami Shimizu; Hidekazu Ino; Kazuyasu Okeie; Masato Yamaguchi; Mitsuru Nagata; Kenshi Hayashi; Hideki Itoh; Taku Iwaki; Kotaro Oe; Tetsuo Konno; Hiroshi Mabuchi
Journal:  Clin Cardiol       Date:  2002-07       Impact factor: 2.882

7.  T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity.

Authors:  Masato Yamaguchi; Masami Shimizu; Hidekazu Ino; Hidenobu Terai; Katsuharu Uchiyama; Kotaro Oe; Tomohito Mabuchi; Tetsuo Konno; Tomoya Kaneda; Hiroshi Mabuchi
Journal:  Clin Sci (Lond)       Date:  2003-12       Impact factor: 6.124

8.  Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death.

Authors:  A W Haider; M G Larson; E J Benjamin; D Levy
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

9.  QT dispersion in essential hypertension.

Authors:  P B Clarkson; A A Naas; A McMahon; C MacLeod; A D Struthers; T M MacDonald
Journal:  QJM       Date:  1995-05

10.  QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.

Authors:  C P Day; J M McComb; R W Campbell
Journal:  Br Heart J       Date:  1990-06
View more
  3 in total

1.  The Effect of Chronic Anabolic-Androgenic Steroid Use on Tp-E Interval, Tp-E/Qt Ratio, and Tp-E/Qtc Ratio in Male Bodybuilders.

Authors:  Elnur Alizade; Anıl Avcı; Serdar Fidan; Mustafa Tabakçı; Mustafa Bulut; Regayip Zehir; Zeki Simsek; Mert Evlice; Uğur Arslantaş; Hakan Çakır; Mehmet Yunus Emiroglu; Mustafa Akçakoyun
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-01-28       Impact factor: 1.468

2.  Impact of Iron and Homocysteine Levels on T Peak-to-End Interval and Tp-e/QT Ratio in Elite Athletes.

Authors:  Serkan Duyuler; Pınar Türker Duyuler; Mustafa Kemal Batur
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-03-28       Impact factor: 1.468

3.  Influence of Football on Physiological Cardiac Indexes in Professional and Young Athletes.

Authors:  Cristian V Francavilla; Francesco Sessa; Monica Salerno; Giuseppe D Albano; Ines Villano; Giovanni Messina; Fabio Triolo; Lorenzo Todaro; Maria Ruberto; Gabriella Marsala; Orazio Cascio; Maria P Mollica; Vincenzo Monda; Giuseppe Cibelli; Anna Valenzano; Christian Zammit; Marcellino Monda; Antonietta Messina
Journal:  Front Physiol       Date:  2018-02-28       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.